This isn't just a stock to be shorted. It is a company that has a future with promising drug candidates, fairly deep pipeline, and an intellectual staff capable of great accomplishments. This is why the high target.
I concur, not only with buying, but the management team, staff and the direction of this company is exceptional. It gives me confidence in my investment.